A startup dream has been realized, while an old pharma company tries to turn a new leaf.
On Monday, 60-year-old Purdue Pharma announced a strategic partnership with Exicure, a 2009 startup that could pull as much as $790 million and royalties if its drug candidates succeed.
{iframe}http://medcitynews.com/2016/12/purdue-exicure-sign-deal-worth-790m/?utm_source=hs_email&utm_medium=email&utm_content=39157650&_hsenc=p2ANqtz-87GXpkfi1Tro3OZI8L2lz5P6oDSQxbIUBd8Tc9CJAvGpRClfSibCw__ux6bRiz2FSZXtYn4u-iQEWWOupIi5t7TJqOpw&_hsmi=39157650{/iframe}